Pancreatic Cancer Diagnostics Using Artificial Intellgence Market Shares, Strategies, and Forecasts, Worldwide, 2017-2023
The 2017 study has 75 pages, 28 tables and figures. Worldwide markets are poised to achieve continuing growth as the artificial intelligence software increases diagnostic excellence, saving lives and lowering care delivery costs.
Automated cancer diagnostics are implemented with artificial intelligence. Systems are able to take a multi-disciplinary integrated approach to looking at imaging and scans. The analysis of patient records, looking for effectiveness of particular treatments is more work than a human can do, the quantity of data is too high, so the artificial intelligence is being used to do that. Systems are making a significant difference in saving lives.
Much of the hospital artificial intelligence market is centered on improving diagnosis and treatment of cancer through the visualization provided by radiology. The systems are able to track and analyze more data, more accurately than can the humans. Radiologists receive years of training. They are among the highest paid doctors, also among the first group of physicians utilizing artificial intelligence because of the complexity of the task to be done.
“Artificial intelligence expands into health care leveraging insight from radiological studies and diagnostics. Radiologists have a deluge of patient data that the artificial intelligence can manage in some ways. This contributes to earlier cancer diagnosis.”
Artificial Intelligence for Hospital Cancer Diagnostics Market Forecasts AI is set to become a sophisticated diagnostic aid, flagging images that humans should examine more closely, while leaving radiologists with more time for interacting with patients and medical staff. Hospital artificial intelligence market shipments at $1.7 billion in 2023 are forecast to reach $11.4 billion dollars, worldwide 2023.
Automated cancer diagnostics are implemented with artificial intelligence. Systems are able to take a multi-disciplinary integrated approach to looking at imaging and scans. The analysis of patient records, looking for effectiveness of particular treatments is more work than a human can do, the quantity of data is too high, so the artificial intelligence is being used to do that. Systems are making a significant difference in saving lives.
Much of the hospital artificial intelligence market is centered on improving diagnosis and treatment of cancer through the visualization provided by radiology. The systems are able to track and analyze more data, more accurately than can the humans. Radiologists receive years of training. They are among the highest paid doctors, also among the first group of physicians utilizing artificial intelligence because of the complexity of the task to be done.
“Artificial intelligence expands into health care leveraging insight from radiological studies and diagnostics. Radiologists have a deluge of patient data that the artificial intelligence can manage in some ways. This contributes to earlier cancer diagnosis.”
Artificial Intelligence for Hospital Cancer Diagnostics Market Forecasts AI is set to become a sophisticated diagnostic aid, flagging images that humans should examine more closely, while leaving radiologists with more time for interacting with patients and medical staff. Hospital artificial intelligence market shipments at $1.7 billion in 2023 are forecast to reach $11.4 billion dollars, worldwide 2023.
ABSTRACT: APPROACHING PANCREATIC CANCER WITH ARTIFICIAL INTELLIGENCE DIAGNOSTICS VASTLY IMPROVES OUTCOMES
Artificial Intelligence (AI) Cancer Diagnostics Executive Summary
Artificial Intelligence (AI) Cancer Diagnostics Market Driving Forces
Artificial Intelligence Cancer Diagnostics Market Shares:
Artificial Intelligence Cancer Diagnosis Market Forecasts:
1. ARTIFICIAL INTELLIGENCE CANCER DIAGNOSTICS MARKET DESCRIPTION AND MARKET DYNAMICS:
1.1 Artificial Intelligence Very Big Breakthrough in Cancer Diagnostics
1.2 Ability of AI Solutions To Discover Schemas in Large Databases
2. ARTIFICIAL INTELLIGENCE (AI) CANCER DIAGNOSTICS MARKET DRIVING FORCES
2.1 Artificial Intelligence (AI) Cancer Diagnostics Market Driving Forces
2.2 Artificial Intelligence Cancer Diagnostics Market Shares:
2.3 Artificial Intelligence for Cancer Diagnostics Market Forecasts:
2.4 Cancer Statistics
2.5 Hospital Artificial Intelligence (AI) Challenges
2.6 Hospital Artificial Intelligence Software Prices:
2.7 Hospital Artificial Intelligence Regional Segments:
3. HOSPITAL ARTIFICIAL INTELLIGENCE PRODUCTS:
3.1 Partners HealthCare, IBM, and GE Healthcare
3.2 IBM Watson
3.2.1 IBM Genomic And Immunotherapy Supercomputing for Patient Management
3.2.2 Mayo Clinic and IBM Watson
3.3 Google’s AI Subsidiary DeepMind is Partnering With Another UK hospital
3.4 Prognos
4. HOSPITAL ARTIFICIAL INTELLIGENCE RESEARCH AND TECHNOLOGY:
4.1 Research at Google
4.2 IBM AI Research
4.2.1 Neural Representation of Sketch Drawings
4.3 Google and Nvidia Artificial Intelligence
5. HOSPITAL ARTIFICIAL INTELLIGENCE COMPANIES
5.1 Alphabet / Google
5.1.1 Google Artificial Intelligence Subsidiary DeepMind Healthcare Initiative
5.2 General Electric (GE)
5.2.1 General Electric Revenue by Segment
5.2.2 GE Healthcare and Massachusetts General Artificial Intelligence
5.3 IBM
5.3.1 IBM Watson Genomics by Quest Diagnostics
5.3.2 IBM Watson Healthcare Revenue
5.3.3 IBM Watson Solutions Software Healthcare Revenue
5.4 Prognos
5.4.1 Coding Healthcare Datasets Full Of Unstructured Text
5.5 Quest Diagnostics
5.5.1 IBM Personalized Healthcare: Watson Genomics from Quest Diagnostics
5.5.2 Quest Diagnostics Revenue
5.6 Safeguard Scientifics Announces Second Quarter 2017 Financial Results
5.6.1 Safeguard Scientifics Prognos DxCloud
Artificial Intelligence (AI) Cancer Diagnostics Executive Summary
Artificial Intelligence (AI) Cancer Diagnostics Market Driving Forces
Artificial Intelligence Cancer Diagnostics Market Shares:
Artificial Intelligence Cancer Diagnosis Market Forecasts:
1. ARTIFICIAL INTELLIGENCE CANCER DIAGNOSTICS MARKET DESCRIPTION AND MARKET DYNAMICS:
1.1 Artificial Intelligence Very Big Breakthrough in Cancer Diagnostics
1.2 Ability of AI Solutions To Discover Schemas in Large Databases
2. ARTIFICIAL INTELLIGENCE (AI) CANCER DIAGNOSTICS MARKET DRIVING FORCES
2.1 Artificial Intelligence (AI) Cancer Diagnostics Market Driving Forces
2.2 Artificial Intelligence Cancer Diagnostics Market Shares:
2.3 Artificial Intelligence for Cancer Diagnostics Market Forecasts:
2.4 Cancer Statistics
2.5 Hospital Artificial Intelligence (AI) Challenges
2.6 Hospital Artificial Intelligence Software Prices:
2.7 Hospital Artificial Intelligence Regional Segments:
3. HOSPITAL ARTIFICIAL INTELLIGENCE PRODUCTS:
3.1 Partners HealthCare, IBM, and GE Healthcare
3.2 IBM Watson
3.2.1 IBM Genomic And Immunotherapy Supercomputing for Patient Management
3.2.2 Mayo Clinic and IBM Watson
3.3 Google’s AI Subsidiary DeepMind is Partnering With Another UK hospital
3.4 Prognos
4. HOSPITAL ARTIFICIAL INTELLIGENCE RESEARCH AND TECHNOLOGY:
4.1 Research at Google
4.2 IBM AI Research
4.2.1 Neural Representation of Sketch Drawings
4.3 Google and Nvidia Artificial Intelligence
5. HOSPITAL ARTIFICIAL INTELLIGENCE COMPANIES
5.1 Alphabet / Google
5.1.1 Google Artificial Intelligence Subsidiary DeepMind Healthcare Initiative
5.2 General Electric (GE)
5.2.1 General Electric Revenue by Segment
5.2.2 GE Healthcare and Massachusetts General Artificial Intelligence
5.3 IBM
5.3.1 IBM Watson Genomics by Quest Diagnostics
5.3.2 IBM Watson Healthcare Revenue
5.3.3 IBM Watson Solutions Software Healthcare Revenue
5.4 Prognos
5.4.1 Coding Healthcare Datasets Full Of Unstructured Text
5.5 Quest Diagnostics
5.5.1 IBM Personalized Healthcare: Watson Genomics from Quest Diagnostics
5.5.2 Quest Diagnostics Revenue
5.6 Safeguard Scientifics Announces Second Quarter 2017 Financial Results
5.6.1 Safeguard Scientifics Prognos DxCloud
LIST OF TABLES AND FIGURES
Abstract: Approaching Pancreatic Cancer with Artificial Intelligence Diagnostics Vastly Improves Outcomes
Figure 1. Artificial Intelligence Cancer Diagnostics Market Shares, Software, Dollars, Worldwide, 2016
Figure 2. Artificial Intelligence for Cancer Diagnosis Market Shipments Forecasts Dollars, Worldwide, 2017-2023
Figure 3. Cancer Artificial Intelligence Components
Figure 4. Hospital Artificial Intelligence Predictive Functions
Figure 5. Artificial Intelligence Cancer Diagnostics (AI) Market Driving Forces
Figure 6. Healthcare Safety Features Implemented by Artificial Intelligence (AI)16
Figure 7. Artificial Intelligence Cancer Diagnostics Market Shares, Software, Dollars, Worldwide, 2016
Figure 8. Artificial Intelligence for Cancer Diagnostics Market Shares, Dollars, Worldwide, 2016
Figure 9. Artificial Intelligence for Cancer Diagnostics Market Shipments Forecasts Dollars, Worldwide, 2017-2023
Figure 10. Artificial Intelligence for Cancer Diagnostics Market Shipments Forecasts Dollars, Worldwide, 2017-2023
Figure 11. AI Replacements for Supervised Manual Techniques For Diagnosis And Care Delivery.
Figure 12. Hospital Artificial Intelligence Long-Term Goal
Figure 13. Hospital Artificial intelligence Action Functions
Figure 14. Pancreatic Cancer Survival Rate
Figure 15. Hospital Artificial Intelligence (AI) Challenges
Figure 16. Hospital Artificial Intelligence (AI) Human Factors
Figure 17. Hospital Artificial Intelligence Software, US and Worldwide, Shipments Forecast, Dollars, Worldwide, 2017-2019
Figure 18. Hospital Artificial Intelligence Regional Market Segments, 2016
Figure 19. Hospital Artificial Intelligence Regional Market Segments, 2016
Figure 20. Truven Health Analytics Products
Figure 21. IBM TrueNorth Neurosynaptic System
Figure 22. AI Makes Words Manageable
Figure 23. GE Healthcare and Massachusetts General Artificial Intelligence Healthcare Initiative Workflow
Figure 24. GE Healthcare and Massachusetts General Artificial Intelligence Healthcare Initiative Center of Excellence
Figure 25. Prognos Investors
Figure 26. Percent Patients with Abnormally High Test 5 years Prior to First Pancreatic Cancer Diagnosis Stratified by Test and by Year
Figure 27. Prognos Pancreatic Cancer Diagnosis Test Result Variance
Figure 28. Watson Genomics from Quest Diagnostics Features:
Abstract: Approaching Pancreatic Cancer with Artificial Intelligence Diagnostics Vastly Improves Outcomes
Figure 1. Artificial Intelligence Cancer Diagnostics Market Shares, Software, Dollars, Worldwide, 2016
Figure 2. Artificial Intelligence for Cancer Diagnosis Market Shipments Forecasts Dollars, Worldwide, 2017-2023
Figure 3. Cancer Artificial Intelligence Components
Figure 4. Hospital Artificial Intelligence Predictive Functions
Figure 5. Artificial Intelligence Cancer Diagnostics (AI) Market Driving Forces
Figure 6. Healthcare Safety Features Implemented by Artificial Intelligence (AI)16
Figure 7. Artificial Intelligence Cancer Diagnostics Market Shares, Software, Dollars, Worldwide, 2016
Figure 8. Artificial Intelligence for Cancer Diagnostics Market Shares, Dollars, Worldwide, 2016
Figure 9. Artificial Intelligence for Cancer Diagnostics Market Shipments Forecasts Dollars, Worldwide, 2017-2023
Figure 10. Artificial Intelligence for Cancer Diagnostics Market Shipments Forecasts Dollars, Worldwide, 2017-2023
Figure 11. AI Replacements for Supervised Manual Techniques For Diagnosis And Care Delivery.
Figure 12. Hospital Artificial Intelligence Long-Term Goal
Figure 13. Hospital Artificial intelligence Action Functions
Figure 14. Pancreatic Cancer Survival Rate
Figure 15. Hospital Artificial Intelligence (AI) Challenges
Figure 16. Hospital Artificial Intelligence (AI) Human Factors
Figure 17. Hospital Artificial Intelligence Software, US and Worldwide, Shipments Forecast, Dollars, Worldwide, 2017-2019
Figure 18. Hospital Artificial Intelligence Regional Market Segments, 2016
Figure 19. Hospital Artificial Intelligence Regional Market Segments, 2016
Figure 20. Truven Health Analytics Products
Figure 21. IBM TrueNorth Neurosynaptic System
Figure 22. AI Makes Words Manageable
Figure 23. GE Healthcare and Massachusetts General Artificial Intelligence Healthcare Initiative Workflow
Figure 24. GE Healthcare and Massachusetts General Artificial Intelligence Healthcare Initiative Center of Excellence
Figure 25. Prognos Investors
Figure 26. Percent Patients with Abnormally High Test 5 years Prior to First Pancreatic Cancer Diagnosis Stratified by Test and by Year
Figure 27. Prognos Pancreatic Cancer Diagnosis Test Result Variance
Figure 28. Watson Genomics from Quest Diagnostics Features:
